Claire Roberts

Claire Roberts currently serves as the VP Head of Clinical Development and Regulatory Affairs at Beckley Psytech, focusing on advancing psychedelics as innovative treatments in neuropsychiatry and overseeing the scientific and medical components of clinical trials. Previous experience includes a role as Senior Director of Neurology Clinical Research at Eisai EMEA, where leadership was provided for Phase 2 and 3 Alzheimer's studies, and as Senior Manager of Clinical Operations, managing clinical projects in epilepsy and Alzheimer's. Claire also held the position of Associate Director of Clinical Sciences at GW Pharmaceuticals plc, leading operations in the U.K., and served as a Clinical Project Manager at Quintiles, managing Phase 3 pain studies while acting as the epilepsy science expert. Educational credentials include a PhD in Pharmacology & Physiology from the University of Nottingham and a BSc in Biochemistry from the University of Bath.